Vaxxinova US Revenue and Competitors
Employee Data
- Vaxxinova US has 89 Employees.
- Vaxxinova US grew their employee count by 11% last year.
Vaxxinova US's People
Name | Title | Email/Phone |
---|---|---|
1 | Head Research And Development | Reveal Email/Phone |
2 | Director Sales and Marketing | Reveal Email/Phone |
3 | Director Manufacturing | Reveal Email/Phone |
4 | Director Swine Business Unit | Reveal Email/Phone |
5 | Director Finance | Reveal Email/Phone |
6 | Key Account Manager | Reveal Email/Phone |
7 | Strategic Account Manager | Reveal Email/Phone |
8 | Accounting Manager | Reveal Email/Phone |
9 | Senior Territory Sales Manager | Reveal Email/Phone |
10 | Maintenance and Engineering Manager | Reveal Email/Phone |
Vaxxinova US Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 10 | -9% | N/A | N/A |
#2 | $1.7M | 31 | 24% | N/A | N/A |
#3 | $35M | 60 | N/A | N/A | N/A |
#4 | $3.5M | 34 | 3% | N/A | N/A |
#5 | $15M | 165 | 23% | N/A | N/A |
#6 | $35M | 502 | 11% | N/A | N/A |
#7 | $15M | 296 | 9% | N/A | N/A |
#8 | N/A | 26 | -4% | N/A | N/A |
#9 | N/A | 34 | 3% | N/A | N/A |
#10 | $3.5M | 63 | 13% | N/A | N/A |
What Is Vaxxinova US?
Vaxxinova US holds a USDA Establishment License No. 365 for the manufacturing of veterinary biologicals. Our mission is to perform discovery, research and development, and manufacturing of technologies to improve animal health and food safety. Vaxxinova US owns intellectual property rights to key technologies, including SRP® Technology, involving the production of highly efficacious and safe veterinary vaccines. We value key partnerships to assist in the marketing and distribution of USDA licensed products in the US and global animal health industries.
keywords:N/AN/A
Total Funding
89
Number of Employees
N/A
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 95 | -7% | N/A |
#2 | $29.2M | 119 | 28% | N/A |
#3 | $26.7M | 124 | 10% | N/A |
#4 | $21.5M | 176 | 3% | N/A |
#5 | N/A | 180 | -1% | N/A |